206 related articles for article (PubMed ID: 34663249)
1. TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study.
Bertozzi S; Londero AP; Viola L; Orsaria M; Bulfoni M; Marzinotto S; Corradetti B; Baccarani U; Cesselli D; Cedolini C; Mariuzzi L
BMC Cancer; 2021 Oct; 21(1):1118. PubMed ID: 34663249
[TBL] [Abstract][Full Text] [Related]
2. Expression of DNA methylation marker of paired-like homeodomain transcription factor 2 and growth receptors in invasive ductal carcinoma of the breast.
Wan Abdul Rahman WF; Fauzi MH; Jaafar H
Asian Pac J Cancer Prev; 2014; 15(19):8441-5. PubMed ID: 25339043
[TBL] [Abstract][Full Text] [Related]
3. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
Harbeck N; Nimmrich I; Hartmann A; Ross JS; Cufer T; Grützmann R; Kristiansen G; Paradiso A; Hartmann O; Margossian A; Martens J; Schwope I; Lukas A; Müller V; Milde-Langosch K; Nährig J; Foekens J; Maier S; Schmitt M; Lesche R
J Clin Oncol; 2008 Nov; 26(31):5036-42. PubMed ID: 18711169
[TBL] [Abstract][Full Text] [Related]
4. Transcription Factor EB Expression in Early Breast Cancer Relates to Lysosomal/Autophagosomal Markers and Prognosis.
Giatromanolaki A; Sivridis E; Kalamida D; Koukourakis MI
Clin Breast Cancer; 2017 Jun; 17(3):e119-e125. PubMed ID: 28017540
[TBL] [Abstract][Full Text] [Related]
5. AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy.
Shin HJ; Kim H; Oh S; Lee JG; Kee M; Ko HJ; Kweon MN; Won KJ; Baek SH
Nature; 2016 Jun; 534(7608):553-7. PubMed ID: 27309807
[TBL] [Abstract][Full Text] [Related]
6. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.
Nimmrich I; Sieuwerts AM; Meijer-van Gelder ME; Schwope I; Bolt-de Vries J; Harbeck N; Koenig T; Hartmann O; Kluth A; Dietrich D; Magdolen V; Portengen H; Look MP; Klijn JG; Lesche R; Schmitt M; Maier S; Foekens JA; Martens JW
Breast Cancer Res Treat; 2008 Oct; 111(3):429-37. PubMed ID: 17965955
[TBL] [Abstract][Full Text] [Related]
7. Berberine-induced TFEB deacetylation by SIRT1 promotes autophagy in peritoneal macrophages.
Zheng Y; Kou J; Wang P; Ye T; Wang Z; Gao Z; Cong L; Li M; Dong B; Yang W; Li Q; Li H; Wang R; Yang L
Aging (Albany NY); 2021 Feb; 13(5):7096-7119. PubMed ID: 33639613
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.
Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J
Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes.
Cheng H; Qin Y; Fan H; Su P; Zhang X; Zhang H; Zhou G
Diagn Pathol; 2013 Aug; 8():129. PubMed ID: 23915145
[TBL] [Abstract][Full Text] [Related]
10. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
[TBL] [Abstract][Full Text] [Related]
11. Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity.
Davis MB; Liu X; Wang S; Reeves J; Khramtsov A; Huo D; Olopade OI
Mol Cancer; 2013 May; 12(1):40. PubMed ID: 23663560
[TBL] [Abstract][Full Text] [Related]
12. PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.
Absmaier M; Napieralski R; Schuster T; Aubele M; Walch A; Magdolen V; Dorn J; Gross E; Harbeck N; Noske A; Kiechle M; Schmitt M
Int J Oncol; 2018 Mar; 52(3):755-767. PubMed ID: 29328369
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Role of SIRT1-Autophagy Axis in Gastric Cancer.
Qiu G; Li X; Wei C; Che X; He S; Lu J; Wang S; Pang K; Fan L
Dis Markers; 2016; 2016():6869415. PubMed ID: 28070138
[No Abstract] [Full Text] [Related]
14. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
15. Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer.
Schricker G; Napieralski R; Noske A; Piednoir E; Manner O; Schüren E; Lauber J; Perkins J; Magdolen V; Schmitt M; Ulm K; Weichert W; Kiechle M; Martens JWM; Wilhelm OG
Sci Rep; 2018 Nov; 8(1):16861. PubMed ID: 30442983
[TBL] [Abstract][Full Text] [Related]
16. DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.
Maier S; Nimmrich I; Koenig T; Eppenberger-Castori S; Bohlmann I; Paradiso A; Spyratos F; Thomssen C; Mueller V; Nährig J; Schittulli F; Kates R; Lesche R; Schwope I; Kluth A; Marx A; Martens JW; Foekens JA; Schmitt M; Harbeck N;
Eur J Cancer; 2007 Jul; 43(11):1679-86. PubMed ID: 17601725
[TBL] [Abstract][Full Text] [Related]
17. Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.
Skarlos P; Christodoulou C; Kalogeras KT; Eleftheraki AG; Bobos M; Batistatou A; Valavanis C; Tzaida O; Timotheadou E; Kronenwett R; Wirtz RM; Kostopoulos I; Televantou D; Koutselini E; Papaspirou I; Papadimitriou CA; Pectasides D; Gogas H; Aravantinos G; Pavlidis N; Arapantoni P; Skarlos DV; Fountzilas G
Cancer Chemother Pharmacol; 2012 Feb; 69(2):533-46. PubMed ID: 21901395
[TBL] [Abstract][Full Text] [Related]
18. The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer.
Habashy HO; Rakha EA; Ellis IO; Powe DG
Breast Cancer Res Treat; 2013 Jul; 140(2):307-16. PubMed ID: 23887673
[TBL] [Abstract][Full Text] [Related]
19. Ligand-activated progesterone receptor B activates transcription factor EB to promote autophagy in human breast cancer cells.
Tan S; Bajalovic N; Wong ESP; Lin VCL
Exp Cell Res; 2019 Sep; 382(1):111433. PubMed ID: 31100306
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the transcription factor EB-PGC1α axis by beclin-1 controls mitochondrial quality and cardiomyocyte death under stress.
Ma X; Liu H; Murphy JT; Foyil SR; Godar RJ; Abuirqeba H; Weinheimer CJ; Barger PM; Diwan A
Mol Cell Biol; 2015 Mar; 35(6):956-76. PubMed ID: 25561470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
